Les Meilleures Cliniques et Coûts d'oncologie en 2026 en Inde

Pendant 16 mois, notre équipe clinique a réalisé 410 chirurgies robotisées avec un taux de réussite de plus de 99 %. Il s'agit notamment des interventions robotiques pour les tumeurs malignes et bénignes, ainsi que des chirurgies bariatriques. Les patients préfèrent la chirurgie robotique car elle se caractérise par des taux de réussite élevés et une douleur minime.

Le Conseil indien de la recherche médicale prévoit environ 1 390 000 nouveaux cas de cancer en 2021. Cela fait des maladies malignes l’une des maladies les plus courantes en Inde. Le principal problème du traitement du cancer réside dans les coûts excessifs. L'Inde propose toutes les dernières techniques (chirurgicales et non chirurgicales) à un coût inférieur à celui de la plupart des pays. Dans le même temps, la qualité et l’efficacité du traitement sont tout aussi élevées .

Le rétablissement complet d’un cancer est un sujet controversé. Si une personne a eu un cancer, il y a toujours une chance qu’il réapparaisse. En 14 ans, nous avons traité plus de 90 000 patients atteints de tumeurs malignes à Nasik, Maharashtra, en Inde. Chez beaucoup d’entre eux, la maladie ne s’est pas manifestée pendant toute la période d’observation. Certains ont eu des rechutes qui, grâce à notre traitement, sont entrées en rémission. Malheureusement, une petite proportion de patients atteints d’un cancer à un stade avancé ne parviennent pas à vaincre la maladie. Notre objectif principal est de guérir le cancer et de prolonger la vie autant que possible. De plus, quel que soit le nombre d’années qu’un patient peut vivre, la qualité de sa vie est primordiale.

A tumour board is a multidisciplinary team of specialists. It includes surgeons, oncologists, and pathologists who decide on a cancer treatment plan together. For oncology cases in India, this review is the standard approach. It ensures balanced care by removing individual bias and following international guidelines.

• Multidisciplinary team: Includes experts in medical, surgical, and radiation oncology, plus radiology and pathology.
• Clinical benefit: Boards catch staging errors and adjust the timing of chemotherapy, surgery, or radiation.
• Quality signal: Structured reviews at centres like Artemis Hospitals suggest higher coordinated decision-making standards.
• Efficiency: One review replaces multiple second opinions, saving time for complex or rare cases.

Bookimed Expert Insight: Patient volume directly affects tumour board efficacy. Clinics like Apollo Hospital Indraprastha and Manipal Hospitals serve over 1,000,000 patients annually. This case volume means their boards have reviewed almost every cancer subtype. This gives them a deeper database for comparison than smaller, local facilities.

Patient Consensus: Patients in India feel more confident when a panel reviews their actual imaging and pathology. They appreciate friendly staff and doctors who clearly explain these collaborative plans. Many suggest having a companion to help navigate hospital logistics.

Leading Indian oncologists provide remote second opinions through digital consultations. Patients can access specialist reviews for various cancers, including leukaemia and breast tumours. They do this by submitting pathology reports and radiology scans. These reviews often include a multidisciplinary tumour board assessment to confirm diagnosis and staging.

• Specialist expertise: Dr Sidharth Sahni serves as a breast surgical oncologist for multiple international embassies.
• Expert review: Dr Surender Dabas has performed over 8,000 head-neck and thoracic cancer surgeries.
• Bone marrow insights: Dr Dharma Choudhary leads the Bone Marrow Transplant Department at BLK Hospital.
• Radiation oncology: Dr S Hukku has over 40 publications in international scientific journals.

Bookimed Expert Insight: Clinics like Artemis or Manipal handle many international patients. These centres have streamlined systems for remote file review. They treat 1,000,000+ patients annually, which leads to faster processing of digital files. This setup allows specialists to return structured treatment recommendations within days without immediate travel.

Patient Consensus: Patients find that Indian specialists explain all treatment options clearly. They provide new drug suggestions and hope for recovery. While some mention hospital wait times, they praise the surgical expertise and the thorough digital test results.

Indian oncology centres provide precision therapies including immunotherapy and targeted therapy. Major facilities in Delhi and Bengaluru use next-generation sequencing to create personalised plans. These treatments target specific genetic mutations and proteins to treat breast, lung, and blood cancers effectively.

• Therapy range: Immunotherapy ranges from Prix sur demande to Prix sur demande for various stages.
• Specific drugs: Immunotherapy including Keytruda costs between Prix sur demande and Prix sur demande per cycle.
• Diagnostic tools: PET/CT scans for precise staging cost from $400 to $600.
• Personalised care: Specialists like Dr Sarat Chandra P at Manipal Hospitals focus on precision medicine.

Bookimed Expert Insight: India is becoming a hub for indigenous precision medicine breakthroughs. Global drug brands are available. However, homegrown innovations like NexCAR19 therapy offer cellular treatment at significantly lower costs than imported alternatives. This makes high-level biological therapy accessible to international patients who find Western prices prohibitive.

Patient Consensus: Patients in India find the clinical level of surgery and drug selection impressive. They recommend having support for logistics. They also note that medical expertise and English-speaking doctors provide high-quality care.

Indian oncology centres use the same primary chemotherapy medications as Australia. Both nations follow international standards like guidelines from NCCN and ESMO. While active chemical compounds are identical, India relies on domestically produced generics. This reduces medical costs while maintaining efficacy for standard cancer treatments.

• Drug overlap: Clinics use standard agents including Cisplatin, Paclitaxel, and 5-Fluorouracil.
• Generic manufacturing: Indian facilities primarily use high-quality local generics instead of originators.
• Regulatory speed: India often approves and stocks new immunotherapy drugs very rapidly.
• Accredited facilities: Leading centres like Apollo Hospital Indraprastha hold JCI accreditation.

Bookimed Expert Insight: Leading Indian specialists like Dr Sidharth Sahni at Apollo Hospital serve high-level Australian entities. This helps local treatment plans align with Western expectations. Our data shows JCI-accredited clinics in major cities manage 1,000,000+ international patients yearly. These high volumes mean hospital pharmacies stock fresh batches of chemotherapy drugs. This constant turnover helps maintain medicine potency at its peak.

Patient Consensus: Patients find that Indian oncologists prescribe innovative drugs and internationally recognised regimens. These plans closely match Australian protocols. The clinical care and surgical results are highly professional. However, navigating hospital organisation is easier with an accompanying person.

Oncology patients in India typically move from consultation to diagnosis within 32 days. Treatment starts quickly after, averaging 20 days. Private centres like Apollo Hospital Indraprastha often fast-track this process. They coordinate staging and surgery within 7 to 14 days for urgent cases.

• Diagnostic turnaround: Definitive tests including biopsy and PET-CT usually take about 32 days.
• Treatment initiation: Median time from confirmed diagnosis to starting therapy is 20 days.
• Clinical variation: Urgent haematological cases start in 11 days. Radiotherapy requires 27–30 days.
• Hospital systems: Integrated centres like Manipal Hospitals coordinate pathology and radiology to reduce delays.

Bookimed Expert Insight: Large Indian networks often re-validate pathology slides from smaller clinics for accuracy. Patients can save roughly 5 to 7 days by bringing original biopsy slides to their first appointment. This prevents the need for a new biopsy before starting treatment.

Patient Consensus: Patients note that major hospitals move very fast once you arrive. While repeat testing is common for safety, international visitors appreciate how specialists coordinate care in one location. India provides a good level of care at high-volume tertiary centres.

International patients access supportive and palliative care through India’s major private hospital networks and oncology hubs. Leading centres integrate pain management, nutritional counselling, and psychosocial support into treatment. Facilities like Apollo Hospital Indraprastha and Manipal Hospitals use specialised international desks to coordinate these services.

• Multidisciplinary approach: Major hospitals include symptom relief in active chemotherapy and radiotherapy protocols.
• Specialised pain management: Care teams use medications and localised therapies for chronic pain.
• Psychosocial resources: Counselling services help international patients and their families navigate intensive treatment.
• Nutritional support: Targeted dietary plans offset side effects from surgeries or systemic therapies.

Bookimed Expert Insight: India’s third-largest healthcare provider, Manipal Hospitals, manages roughly 2,000,000 patients annually. Data shows that larger systems like this or Apollo Hospital Indraprastha provide robust infrastructure. Patients should confirm that symptom management teams are available from the day of diagnosis.

Patient Consensus: Patients report that while medical treatment is high-quality, having a coordinator is essential. They note that hospital food is excellent and private bays provide comfort during recovery.

Les soins de santé en Inde reposent sur des modèles rentables. La plupart des hôpitaux sont privés : 65 % du PIB annuel provient des paiements directs pour les services médicaux.

1,4 million de médecins dispensent d'excellents soins dans le pays. 74 % des soins de santé en Inde sont privés. Les centres médicaux locaux disposent de certificats internationaux et nationaux confirmant la haute qualité des services et la sécurité des patients :

• JCI (Joint Commission International) est une organisation internationale visant à améliorer la qualité et la sécurité des services médicaux dans le monde.
• Le NABH (National Accreditation Board of Hospitals and Healthcare Providers) est un conseil indien de qualité qui organise l'accréditation des centres médicaux du pays.

L'Inde compte 39 centres médicaux accrédités JCI, contre 20 établissements certifiés JCI en Allemagne et 10 hôpitaux en Israël.

Il existe des hôtels de différentes gammes de prix et niveaux de service en Inde . La plupart des touristes choisissent des hôtels 4 et 5 étoiles. Ces hôtels ont tout pour un séjour confortable : une variété de plats européens et asiatiques, un vaste terrain bien entretenu, des animations pour enfants et adultes. Certains hôtels mettent un parc aquatique à la disposition des clients. Les voyageurs à petit budget peuvent se permettre de réserver un hôtel 3 étoiles économique avec demi-pension ou sans repas du tout.

Les patients étrangers doivent obtenir un visa électronique (e-Visa). La durée maximale de séjour dans le pays pour ce type de visa est de 6 mois. En savoir plus sur les conditions d'obtention d'un visa pour se faire soigner en Inde ici .

Un visa pour voyager en Inde nécessite un certain nombre de documents . La liste des documents requis comprend :

• Carte d'identité
• copie du formulaire de demande de visa en ligne
• attestation de revenus et disponibilité des fonds
• dernières photos taille 2
• un justificatif d'adresse résidentielle
• réservation de vol et d'hôtel
• rapport médical sur la nécessité d'un traitement en Inde.